A new ex vivo drug delivery system has been shown to keep MSCs viable longer and reprogram the peripheral immune response toward organ repair. The study's results suggest that SBI-101 can impact a peripheral immune response that can be transmitted to local tissue damage in vital organs, including the kidney.
Researchers link repeated injury to airway stem cells with chronic lung disease, suggesting that biological aging of these cells may contribute to the development of this condition. The study found that injury caused activation of a subset of stem cells, leading to their premature aging and loss of functional capacity.
A study found that treating wounds with mesenchymal stromal cell secretions significantly reduced MRSA viability and stimulated the surrounding skin cells to build a defense. The treatment has potential as an alternative to antibiotics, reducing antibiotic resistance in both veterinary and human medicine.
Researchers have discovered that the TRPV4 gene plays a crucial role in regulating cartilage growth, which could lead to more effective treatments for osteoarthritis and other cartilage diseases. The study also suggests that TRPV4 may be used to accelerate stem cell differentiation for bioengineering cartilage.
A new clinical study reveals that treatment with mesenchymal stromal cells reduces inflammation in patients with chronic obstructive pulmonary disease (COPD). The study provides insights into the therapeutic potential of MSCs as a novel treatment for COPD, which is a leading cause of morbidity and mortality worldwide.
Researchers used autologous adipose micrografts to treat tendon injuries in sheep, achieving similar diameter and hardness to healthy tendons within two months. The study suggests a safe, reliable, and relatively fast way to promote tendon healing, with potential for human treatment.
A study confirmed the safety of a novel stem cell therapy for knee pain caused by osteoarthritis. The treatment, which involves transplanting patient's own mesenchymal stem cells into the affected knee, showed no serious side effects over five years.
A compassionate-use study released in STEM CELLS Translational Medicine found significant improvement in body muscles with mesenchymal stem cells derived from Wharton's jelly, a substance in the umbilical cord. The treatment resulted in improved muscle strength and function without serious side effects.
Researchers at Newcastle University have successfully created a model of lung cells using induced pluripotent stem cells, which can be used to replicate how COVID-19 infects the airways. The model has shown that it is capable of secreting mucus and being infected by SARS-CoV-2, paving the way for broader studies on viral lung infections.
A clinical trial found that non-altered stem cells from umbilical cord connective tissue increased the survival of critically ill COVID-19 patients by 2.5 times. The treatment also showed a fourfold increase in survival for patients with chronic health conditions.
Researchers found that autologous bone marrow stromal stem cells can lower blood glucose levels and reduce medication doses in non-obese Type 2 diabetes patients with a short disease duration. The study's results are promising for the potential treatment of this chronic disease.
A study reveals that secreted cell factors, particularly TGFβ1, inhibit hematopoiesis in humans with acute myeloid leukemia. Blocking TGFβ1 could improve hematopoiesis in AML patients.
Researchers have developed a new model of NTM lung infection and found that human mesenchymal stem cells (hMSCs) are effective in treating this condition. The study identified donor-specific hMSC potency against NTMs, which could lead to improved treatment outcomes for patients with chronic NTM lung disease.
Researchers assessed the effectiveness of treating preterm infants with umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) directly into their tracheas. Early results showed signs of improvement for the most immature infants included in the trial, but further study is needed to solidify therapeutic benefits.
Researchers found that applying fat grafts enriched with adipose-derived stem cells improved fat retention in LoS patients. The study suggested a safe and feasible alternative to conventional treatment methods for correcting facial atrophy.
Researchers found that aged bone marrow niches restrict the function of rejuvenated hematopoietic stem cells, which can lead to leukemia. The study suggests that addressing the influence of an aged niche is crucial for sustaining the function of rejuvenated HSCs.
A new stem cell therapy has induced regeneration of blood vessels surrounding non-healing diabetic foot ulcers, accelerating healing. The treatment uses adult stem cells harvested from fat tissue, demonstrating a novel cell injection therapy that can alleviate pain and infection.
A study by researchers at Warwick Medical School reveals that decidual precursor cells play a critical role in pregnancy and their depletion may lead to recurrent pregnancy loss. The study suggests that these cells can be harnessed to prevent pregnancy disorders, offering new hope for women struggling with miscarriage.
Researchers discovered that ferulic acid primed stem cells can repair bone damage caused by radiation. The study found that FA enhances the bone repair effects of skeletal stem cells by activating specific pathways, making it a potential novel strategy in treating irradiated bone injury.
Researchers at UPMC demonstrated that allogeneic adipose-derived stem cells (ASCs) can mitigate acute radiation syndrome, a condition known as total body irradiation. ASCs were found to improve survival rates and repair damage to the hematopoietic system in mice exposed to high levels of radiation.
A clinical trial revealed that bone marrow cell injections can lead to a reduction in brain injury after a stroke, with improvements seen in the corticospinal tract 12 months post-treatment. The study suggests a potential approach for regenerative therapies to improve brain health for millions of patients affected by stroke.
A phase I clinical trial reveals adipose-derived stem cells alleviate symptoms of lymphedema, improving upper extremity function and reducing treatment use. Patients experienced sustained benefits for up to four years after treatment.
Researchers identify a unique population of skeletal stem cells that mark a transitional phase in bone growth and maintenance, which may hold clues to preventing osteoporosis. The study's findings provide new insights into the regulation of these cells and their potential role in bone health.
A clinical trial evaluated the safety and effectiveness of two cell therapies for treating angiitis-induced critical limb ischemia, yielding satisfactory results. The study found that both therapies provided evidence for precise application under different conditions.
Researchers at Sungkyunkwan University found that stem cell-derived extracellular vesicles can reduce severe intraventricular hemorrhage-induced brain injuries in newborn rats. The neuroprotection is primarily mediated by BDNF transfer via EVs, providing a promising potential treatment for bleeding in the brain.
Scientists have identified a key gene mechanism controlling cellular aging and rejuvenation in mesenchymal stem cells. The GATA6/SHH/FOXP1 pathway regulates MSC aging and rejuvenation, offering insights into developing treatments for age-related diseases.
Researchers found that pre-treating early outgrowth cells with a chemical activator slows the development of atherosclerosis in mice. The study showed that this treatment reduced inflammation and plaque buildup in arteries, providing potential hope for treating cardiovascular diseases.
Researchers at Duke University have discovered a mechanism by which mesenchymal stem cells (MSCs) modulate the inflammatory response, extending their beneficial effects even after being cleared from the system. The study sheds light on how MSCs suppress T cell activation and reprogram disease-fighting cells to promote healing.
Researchers at the University of Wisconsin-Madison have discovered a potential new treatment for ligament injuries using exosomes and macrophages. The study found that exosome-educated macrophages can promote ligament healing and reduce scarring, with increased collagen production and reduced scar formation.
A study published in STEM CELLS revealed that fibulin 5 plays a crucial role in the development of Schwann cells, which produce the myelin sheath surrounding neuronal axons. The research suggests that fibulin 5 may be used to treat Charcot-Marie-Tooth disease and other demyelinating disorders.
A study in STEM CELLS Translational Medicine suggests that amniotic fluid stem cell-derived secretome can restore neuronal plasticity and improve cognition after an ischemic stroke. The findings offer a potential new avenue of treatment for ischemic stroke, which affects 87% of all strokes.
Researchers have developed a method to genetically edit out proteins on human pluripotent stem cells that trigger immune rejection. This approach could generate universally compatible 'off-the-shelf' cell grafts without the need for immune suppression, offering a promising solution for regenerative medicine.
A clinical trial indicates that a combination of stem cell therapy and educational intervention can significantly improve social communication, language, and daily skills in children with autism spectrum disorder (ASD). The study found positive changes in various aspects after stem cell transplantation combined with educational interve...
Researchers have developed a bioengineered scaffold using human mesenchymal stem cells and timolol, which significantly improved wound epithelialization and reduced inflammatory response in diabetic mice. The combination therapy resulted in more than a 70% increase in tissue repair compared to the control group.
Researchers developed a non-invasive tracking strategy using CRISPR/Cas9 editing to insert the sodium/iodide symporter gene into iPSCs. This allows long-term monitoring of cardiomyocytes after implantation, paving the way for preclinical and clinical development of cardiac cell therapies.
A clinical trial found that breast augmentation with ASC-enriched fat grafts resulted in significantly better outcomes compared to non-enriched grafts. The study showed improved retention rates and histological appearance of the grafts, making ASCs a promising tool for increasing graft success.
A new study investigates the impact of plastic nanoparticles on human development, finding links to eye development, cardiac malformations, and ischemia. The research highlights the need for urgent action to create regulatory measures to lessen NPs' impact on human health.
Researchers used a 'disease in a dish' stem cell model to examine the mechanism behind retinal ganglion cell degeneration in glaucoma. The study found that cells from individuals with a genetic risk allele for glaucoma were stalled at an immature stage, making them more vulnerable to degeneration.
Researchers have successfully used magnetic targeting to improve the efficacy of mesenchymal stem cells (MSCs) in treating silicosis. The study found that MSCs treated with magnets showed significant reductions in lung damage and improvements in pulmonary function compared to non-magnetized MSCs.
Researchers at A*STAR in Singapore have identified a potential biomarker, GSTT1, to screen the quality of donor's stem cells before harvesting. This biomarker can help determine the growth capacity and potency of MSCs, which is crucial for effective stem cell therapies.
A new study shows that intranasal delivery of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) reduces inflammation in the brain, a prime factor in Alzheimer's disease. The treatment also triggers actions to guard against further degenerative effects.
Researchers found that p53 plays a crucial role in regulating cell division and apoptosis only during pluripotent stem cell differentiation, resolving years of conflicting results. The study used various chemotherapy drugs to induce apoptosis in ESCs and showed that p53 is not essential for cell cycle arrest or apoptosis prior to diffe...
Researchers found that stem cells collected from human amniotic membrane can slow the progression of scarring in pulmonary fibrosis by controlling immune cell activity. This pre-clinical study could lead to new treatments for this deadly disease, affecting 13-20 out of every 100,000 people worldwide.
A recent clinical trial has demonstrated the ability of a stem cell-based topical solution to regrow hair in individuals with androgenetic alopecia, also known as male-pattern baldness. The study found that the treatment led to significant increases in both hair count and follicle diameter.
Researchers demonstrate a potential solution to corneal scarring by using stem cells to regenerate the cornea's stroma. The study shows improved corneal transparency and vision with minimal inflammatory response.
Researchers have developed a novel method to induce regulatory T-cells from mesenchymal stromal cells, which could lead to new treatments for various chronic inflammatory diseases. The study found that MSCs can produce an abundant replacement for naturally occurring T-cells, increasing the count and frequency of Treg-like cells.
New guidelines provide a rational treatment approach for managing skin reactions caused by Epidermal Growth Factor Receptor Inhibitors (EGFRIs), which are used to treat various types of cancer. The recommended treatment involves using moisturizers, protecting against sunlight, and targeted medications to manage the severity of the rash.
Using erythropoiesis-stimulating agents (ESAs) to treat non-chemotherapy-related anemia in cancer patients may increase the risk of death, thromboembolic events, and potentially even cancer growth. Researchers recommend a cautious approach until further scientific data is available.